Sildenafil and Uteroplacental Perfusion

NCT01107782 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Fetal Growth Retardation

Interventions

DRUG: sildenafil
DRUG: placebo

Sponsor

Tehran University of Medical Sciences